☆ 4.6 Review

Traditional Chinese medication for oral submucous fibrosis: A systematic review and network meta-analysis of randomized controlled trials

ORAL DISEASES (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, Research & Experimental

Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms

Xiao Li et al.

Summary: Cardiovascular diseases are a leading global cause of death, with cardiac fibrosis being a common pathological process in cardiac remodeling. Traditional Chinese medicine shows potential in treating cardiac fibrosis, with the identified mechanisms including inflammation attenuation, fibroblast activation inhibition, and modulation of various systems and pathways.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Medicine, Research & Experimental

Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2

Ying Huang et al.

Summary: The study confirmed Tanshinone I as a novel EZH2 inhibitor that regulates normal and malignant hematopoiesis, and identified MMP9 and ABCG2 as potential therapeutic targets for myeloid malignant diseases.

THERANOSTICS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Efficacy of Curcumin and Topical Steroids in the Treatment for Oral Submucous Fibrosis: A Comparative study

T. A. Deepak et al.

Summary: This study aimed to evaluate the efficacy of curcumin in treating OSMF, assess the efficacy of topical steroids, and compare the two treatments. The results demonstrated that curcumin was more efficient than topical steroids for alleviating the clinical findings of OSMF.

JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2021)

Add to Collection

Review Otorhinolaryngology

Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype

Oreste Iocca et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Salvianolic acid B improves myocardial function in diabetic cardiomyopathy by suppressing IGFBP3

Chang-ling Li et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy

Yin-Hwa Shih et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Review Medicine, General & Internal

Efficacy of Salvia miltiorrhiza injection combined with steroids in the treatment of oral submucous fibrosis A meta-analysis of randomized controlled trials

Hui Xie et al.

MEDICINE (2019)

Add to Collection

Article Pharmacology & Pharmacy

Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways

Yuting Zhang et al.

PHARMACOLOGICAL RESEARCH (2019)

Add to Collection

Article Dentistry, Oral Surgery & Medicine

Omega 3: a novel treatment agent in oral submucous fibrosis: a pilot study

Milanjeet Kaur Raizada et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of Tanshinone IIA, Salvianolic Acid A and Salvianolic Acid B on Areca Nut Extract-Induced Oral Submucous Fibrosis in Vitro

Jian-Ping Dai et al.

MOLECULES (2015)

Add to Collection

Article Dentistry, Oral Surgery & Medicine

Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis

Xiao-Wen Jiang et al.

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2013)

Add to Collection

Review Allergy

A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

Dora Liu et al.

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.